We are live on ! Find out more
CCP

Cardan Capital Partners Portfolio holdings

AUM $893M
1-Year Est. Return 22.82%
This Fund
S&P 500
This Quarter Est. Return
+10.44%
1 Year Est. Return
+22.82%
3 Year Est. Return
+64.04%
5 Year Est. Return
+96.69%
10 Year Est. Return
AUM
$810M
AUM Growth
+$57.8M
Cap. Flow
-$7.35M
Cap. Flow %
-0.91%
Top 10 Hldgs %
34.41%
Holding
254
New
18
Increased
85
Reduced
63
Closed
28

Sector Composition

Rank Sector Weight
1 Miscellaneous 71.23%
2 Technology 11.85%
3 Consumer Discretionary 4.34%
4 Communication Services 4.04%
5 Healthcare 3.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VGT icon
201
Vanguard Information Technology ETF
VGT
$147B
$246K 0.03%
5,568
DEO icon
202
Diageo
DEO
$51.7B
$242K 0.03%
1,522
-1,605
-51% -$239K
NTLA icon
203
Intellia Therapeutics
NTLA
$1.8B
$240K 0.03%
+4,410
New +$160K
COLB icon
204
Columbia Banking Systems
COLB
$8.51B
$238K 0.03%
+6,617
New +$205K
MTCH icon
205
Match Group
MTCH
$9.54B
$234K 0.03%
+1,549
New +$205K
UNP icon
206
Union Pacific
UNP
$183B
$234K 0.03%
1,125
+100
+10% +$20K
JOF
207
Japan Smaller Capitalization Fund
JOF
$358M
$228K 0.03%
25,246
SRLP
208
DELISTED
SPRAGUE RESOURCES LP
SRLP
$222K 0.03%
11,702
+461
+4% +$7.86K
BAX icon
209
Baxter International
BAX
$13.5B
$220K 0.03%
2,740
DHR icon
210
Danaher
DHR
$152B
$220K 0.03%
1,116
FSM icon
211
Fortuna Silver Mines
FSM
$3.63B
$220K 0.03%
26,700
CAT icon
212
Caterpillar
CAT
$368B
$219K 0.03%
+1,201
New +$204K
SWZ
213
Swiss Helvetia Fund
SWZ
$77.8M
$218K 0.03%
24,415
ASML icon
214
ASML
ASML
$651B
$216K 0.03%
+442
New +$186K
BMY icon
215
Bristol-Myers Squibb
BMY
$136B
$216K 0.03%
3,485
GRF
216
Eagle Capital Growth Fund
GRF
$40.9M
$214K 0.03%
26,865
INTC icon
217
Intel
INTC
$473B
$211K 0.03%
+4,232
New +$207K
GGZ
218
Gabelli Global Small and Mid-Cap Value Trust
GGZ
$126M
$206K 0.03%
15,765
MCK icon
219
McKesson
MCK
$104B
$205K 0.03%
+1,176
New +$196K
IWD icon
220
iShares Russell 1000 Value ETF
IWD
$84.3B
$204K 0.03%
+1,489
New +$191K
ET icon
221
Energy Transfer Partners
ET
$73.4B
$201K 0.02%
32,527
+8,000
+33% +$48.4K
CCIF
222
Carlyle Credit Income Fund
CCIF
$57M
$126K 0.02%
12,813
STEW
223
SRH Total Return Fund
STEW
$1.79B
$119K 0.01%
10,727
SMM
224
DELISTED
Salient Midstream & MLP Fund
SMM
$104K 0.01%
24,342
HROW icon
225
Harrow
HROW
$1.4B
$70K 0.01%
10,200

Similar funds

Cardan Capital Partners's Q4 2020 Portfolio in Review

As of Q4 2020, Cardan Capital Partners held 254 positions worth $810M, up 7.7% from $753M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Cardan Capital Partners's Q4 2020 filing shows 18 new, 85 increased, 63 reduced and 28 closed positions. Its largest new stake was Amicus Therapeutics: 378,141 shares worth $8.73M. The largest sale was Vanguard Short-Term Treasury ETF, an estimated $15M.

By sector, the portfolio is most concentrated in Miscellaneous at 71% of assets, down from 73% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Cardan Capital Partners's largest Q4 2020 buy was Amicus Therapeutics: 378,141 shares worth $8.73M.
  • Cardan Capital Partners added most to iShares 20+ Year Treasury Bond ETF in Q4 2020, an estimated $29M increase.
  • Cardan Capital Partners's biggest Q4 2020 reduction was Vanguard Short-Term Treasury ETF, cutting an estimated $15M.
  • Cardan Capital Partners fully exited Trane Technologies in Q4 2020, selling an estimated $4.1M.
  • Cardan Capital Partners's ten largest holdings make up 34% of its $810M portfolio in Q4 2020.
  • Cardan Capital Partners opened 18 new positions and closed 28 in Q4 2020.
  • Cardan Capital Partners's portfolio value rose 7.7% quarter-over-quarter to $810M.

Based on Cardan Capital Partners's 13F filing for Q4 2020, filed 27 Jan 2021.